Investor profile
Polaris Partners has backed 11 European tech companies across 14 funding rounds between 2012 and 2026, joining rounds totalling €494M. Most active in Software and Healthtech. Data as of 6 Aug 2026.
Also recorded as: Polaris
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Noema Pharma | Switzerland | 2 | €134M |
| Fire1 | Ireland | 1 | €115M |
| Tropic | UK | 1 | €91M |
| Leyden Labs | Netherlands | 1 | €68M |
| Genomics Medicine Ireland | Ireland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Fire1 | Other | €115M | 2025-01 |
| Noema Pharma | Series B | €105M | 2023-03 |
| Tropic | Series C | €91M | 2026-03 |
| Leyden Labs |
| 1 |
| €36M |
| Twistlock | Israel | 1 | €16M |
| Boxever | Ireland | 2 | €15M |
| Logentries | Ireland | 2 | €8.4M |
| Profitero | Ireland | 1 | €5.9M |
| DocTrackr | France | 1 | €1.8M |
| Memento | Iceland | 1 | €1.2M |
| €68M |
| 2025-01 |
| Genomics Medicine Ireland | Series A | €36M | 2016-10 |
| Noema Pharma | Series B | €29M | 2024-12 |
| Twistlock | Series B | €16M | 2017-04 |
| Boxever | Series B | €11M | 2016-01 |
| Logentries | Series A | €7.6M | 2013-09 |
| Profitero | Other | €5.9M | 2014-06 |
